You know, Bubsy, the talking orange bobcat mascot from the 90s? He's back, with a new 3D game developed by indie studio Fabraz and published by Atari. It's called Bubsy 4D, and it's Bubsy's first 3D ...

Publisher Atari and developer Fabraz have announced Bubsy 4D for PlayStation 5, Xbox Series, Switch 2, PlayStation 4, Xbox One, Switch, and PC (Steam, Epic Games Store, GOG). A release date was not ...

There's a lot to be said about the 90s and somehow not all of it is terrible. Extreme this and edgy that, so much of its pop culture is cringe-worthy tryhard wannabe that it's hard to take seriously.

Platforming Games Indie devs' weirdly promising Bubsy 4D wouldn't exist if the clouds hadn't parted and blessed the Atari CEO with a revelation: "I was like, 'Is this a nationally known IP?'" ...

GameSpot may get a commission from retail offers. Euro Truck Simulator 2 has been only available on PC and Mac since its release in 2013, while American Truck Simulator has been parked on the same ...

Update #2 [Thu 21st Aug 2025, 4:50pm]: Right, we've got some more details on this now! SCS Software has indeed confirmed that Euro Truck Simulator 2 and American Truck Simulator 2 are coming to Xbox, ...

With about 700 million weekly users, ChatGPT is the most popular AI chatbot in the world, according to OpenAI. CEO Sam Altman likens the latest model, GPT-5, to having a PhD expert around to answer ...

When you think of biotech hubs, the first image that comes to mind may be the sleek waterfront offices of Boston Seaport or the scenic hills of San Francisco’s Bay Area. But a small city in ...

Explore the space between the stars from the safety of a virtual cockpit with the best space flight simulation games. Space is one of the most popular settings for video games, and it's easy to see ...

Building a home flight simulator ranges from a few hundred dollars for basic setups to thousands for highly realistic systems. Essential components include a cockpit frame, powerful computer, visual ...

4D Molecular Therapeutics has posted 60-week data on a gene therapy, providing evidence of durability in diabetic macular edema (DME) and sending its stock up more than 40% in premarket trading. The ...